Dr Anna Albecka-Moreau

Name:	Dr Anna Albecka-Moreau
Affiliation:	University of Cambridge
E-mail:	(only provided to users who are logged into talks.cam)
Last login:	13 Jan 2020, 9:06 a.m.

Public lists managed by Dr Anna Albecka-Moreau

Talks given by Dr Anna Albecka-Moreau

Obviously this only lists talks that are listed through talks.cam. Furthermore, this facility only works if the speaker's e-mail was specified in a talk. Most talks have not done this.

Talks organised by Dr Anna Albecka-Moreau

This list is based on what was entered into the 'organiser' field in a talk. It may not mean that Dr Anna Albecka-Moreau actually organised the talk, they may have been responsible only for entering the talk into the talks.cam system.

• Antibodies against Ebola and Lassa: A Global Collaboration
• 'Hitchin' a ride: how herpesviruses modulate host-cell membrane trafficking
• Studying viruses in people using mathematics
• Regulating the balance of cytomegalovirus latency and reactivation through the viral GPCR US28
• Merkel cell polyomavirus: the role of the early gene products during viral life cycle and Merkel cell cancer pathogenesis
• Functional interactions between components involved in alphavirus regulation
• RNA interference as an antiviral immunity in mammals
• Bluetongue virus structure and replication
• Hitchin' a ride: how herpesviruses modulate host-cell membrane trafficking
• Spatiotemporal regulation of host immune defences to HSV-1 infection
• Flavivirus assembly and maturation process
• Emerging virus spillover - overcoming the entry-barrier
• Vaccines for Notorious Zoonotic Viruses
• The viral capsid, a critical determinant of Enterovirus pathogenicity
• Cell-Autonomous Mechanisms of HIV Suppression
• Role of RNA chaperons in segment assortment and RNA packaging of dsRNA viruses
• In pursuit of a broad spectrum antiviral: High resolution structures of antiviral targets in the calnexin cycle
• Mechanisms of influenza A virus modulation of host membrane trafficking
• A Universal Approach to Optimise the Folding and stability of Pre-fusion-Closed Viral Enveloped Trimers
• Alternative Cell Death Pathways in Antiviral Host Defense
• Title to be confirmed
• How Does A Synthetic Antiviral Developed For Influenza Virus Inhibit Other Viruses?
• Emerging Human coronavirus virulence and protection
• Two transmissible cancers in Tasmanian devils
• Life on the edge of equilibrium: The roles of asymmetric components in ssRNA viruses
• Potato mop-top virus co-opts the HIPP26 drought stress sensor for long distance movement
• A novel innate immune antagonist function in influenza A virus?
• Cellular and molecular mechanisms of arbovirus pathogenesis: implications for therapeutic interventions
• The trials and tribulations of using field deployable genomics during epidemic response
• What does endogenising a retrovirus do to its host, the example of koala retrovirus?
• The importins of Herpes Simplex Virus nuclear targeting
• Studying the structure and assembly of HIV-1 and other enveloped viruses using cryo-electron tomography
• Novel insights into HIV assembly and maturation
• Hepatitis B virus cccDNA regulation and spatial nuclear organization
• Cryomicroscopy of viruses, from atomic-resolution structure to in situ 3D imaging
• The role of the host and co-infections in Ebola virus disease and its outcome
• Towards understanding the molecular mechanism(s) of IFITM-mediated restriction of viral entry
• Alphavirus induced inflammatory disease: new insights into disease mechanisms and therapeutic approaches
• Deregulation of long-range gene control in lymphoma: insights from Epstein-Barr virus
• Studying virus infection in cells with new imaging techniques
• Host cell/virus interactions in the late stages of the HIV life cycle
• Papillomavirus sabotage of epithelial growth and differentiation pathways: New targets for intervention?
• Antibody Responses in Dengue and Zika Infection
• The long journey of hepatitis C virus entry into hepatocytes
• Genetic and Proteomic Approaches to Viral Evasion
• Structural insights into how picornaviruses infect cells and how we might stop them
• Kaposi’s sarcoma herpesvirus as a valuable model system for cancer biology research
• Vaccinia virus induces a cytoplasmic DNA damage response to facilitate replication